Five-year reoperation rates following phacoemulsification combined with goniosynechialysis in primary and lens-related angle-closure glaucoma
Related Experiment Video
Updated: Mar 7, 2026

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Jin Wang1, Keyu Hu2, Zijian Liu2
1Beijing Tongren Eye Center, Beijing Tongren Hospital, Beijing Ophthalmology & Visual Sciences Key Laboratory, Capital Medical University, Beijing, China.
Purpose:
To compare reoperation rates following phacoemulsification combined with goniosynechialysis (Phaco-GSL) between patients with primary angle-closure glaucoma (PACG) and angle closure secondary to lens subluxation (ASAC-LS) within 5 years, and to identify risk factors for reoperation.
Design:
Retrospective, comparative cohort study.
Methods:
We analyzed patients with PACG and ASAC-LS who underwent Phaco-GSL at Beijing Tongren Hospital between 2016 and 2021. The primary outcome was reoperation rates within 5 years. Kaplan-Meier analysis compared cumulative reoperation rates, and Cox regression identified risk factors for reoperation.
Results:
Among 3084 PACG and 745 ASAC-LS eyes, the ASAC-LS group showed a significantly higher 5-year reoperation rate (2.3% vs. 0.9%, P = 0.003). Temporal analysis showed a higher risk for patients with ASAC-LS between 31 and 180 days postoperatively. Reoperation indications differed markedly between groups, with intraocular lens subluxation predominating in the ASAC-LS reoperations (50.0%), while uncontrolled intraocular pressure (IOP) was most common in PACG (56.0%). Independent risk factors for reoperation included: age > 60 years (HR = 5.132, P < 0.001), ASAC-LS diagnosis (HR = 3.619, P = 0.004), previous glaucoma surgery (HR = 4.257, P = 0.002), and higher preoperative IOP (HR = 1.043, P = 0.006).
Conclusions:
Patients with ASAC-LS have a higher reoperation risk after Phaco-GSL than those with PACG. Recognizing identified risk factors allows for the optimization of surgical approaches and the development of tailored follow-up protocols for high-risk patients.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Ophthalmic Drug Delivery Systems

